Hypoxia is a prominent feature of the TME and its presence results in the stabilization by cancer cells of hypoxia-inducible factor 1 alpha (HIF-1α), the master regulator of the hypoxic response, leading to the upregulation of a plethora of gene products geared toward the protection of tumor cells against hypoxic stress [4]. Here, HIF1A is linked to neoplasm.